CINECA IRIS Institutional Research Information System

QUAGLINO, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.145
EU - Europa 13.533
AS - Asia 4.740
SA - Sud America 377
AF - Africa 174
OC - Oceania 162
Continente sconosciuto - Info sul continente non disponibili 64
Totale 37.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.847
IT - Italia 3.991
CN - Cina 2.617
IE - Irlanda 1.983
FR - Francia 1.258
DE - Germania 1.228
SE - Svezia 1.085
KR - Corea 770
FI - Finlandia 712
UA - Ucraina 561
GB - Regno Unito 521
AT - Austria 432
PL - Polonia 430
IN - India 348
VN - Vietnam 288
ES - Italia 274
CA - Canada 231
JP - Giappone 227
DK - Danimarca 187
BR - Brasile 174
NL - Olanda 150
AU - Australia 143
TR - Turchia 104
CH - Svizzera 100
BE - Belgio 87
RO - Romania 82
SG - Singapore 82
RU - Federazione Russa 80
GR - Grecia 78
HK - Hong Kong 76
SN - Senegal 68
AR - Argentina 63
EU - Europa 61
PT - Portogallo 55
CO - Colombia 50
MX - Messico 50
NO - Norvegia 48
NG - Nigeria 45
CL - Cile 38
TW - Taiwan 37
HU - Ungheria 34
SI - Slovenia 33
PE - Perù 29
IR - Iran 28
ID - Indonesia 24
RS - Serbia 24
IL - Israele 22
NZ - Nuova Zelanda 19
EG - Egitto 18
CZ - Repubblica Ceca 17
TH - Thailandia 16
HR - Croazia 15
ZA - Sudafrica 14
EC - Ecuador 13
LT - Lituania 11
SA - Arabia Saudita 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
MY - Malesia 9
PH - Filippine 9
UZ - Uzbekistan 9
CR - Costa Rica 8
PK - Pakistan 8
UY - Uruguay 8
AL - Albania 7
AM - Armenia 7
MO - Macao, regione amministrativa speciale della Cina 7
BG - Bulgaria 6
LV - Lettonia 6
MK - Macedonia 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
LK - Sri Lanka 5
BA - Bosnia-Erzegovina 4
EE - Estonia 4
KW - Kuwait 4
LB - Libano 4
JO - Giordania 3
MT - Malta 3
NP - Nepal 3
PA - Panama 3
QA - Qatar 3
A1 - Anonimo 2
FO - Isole Faroe 2
IM - Isola di Man 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CY - Cipro 1
GP - Guadalupe 1
HN - Honduras 1
IQ - Iraq 1
Totale 37.183
Salva come PNG Salva come JPEG
Città #
Chandler 2.730
Dublin 1.972
Beijing 1.479
Houston 912
Fairfield 870
Ashburn 863
Princeton 752
Villeurbanne 720
Medford 691
Torino 656
Wilmington 621
Ann Arbor 550
Jacksonville 543
Woodbridge 480
Redwood City 433
Vienna 409
Nyköping 386
Warsaw 371
Dearborn 339
Seattle 336
Cambridge 327
Boston 257
Pisa 253
Milan 247
Dong Ket 182
New York 158
Turin 153
Hebei 129
Rome 114
Pune 109
Boardman 106
Norwalk 100
Washington 92
Shanghai 91
Guangzhou 90
Toronto 88
Nanjing 86
Hangzhou 82
Chengdu 80
Fremont 72
Seoul 66
Hefei 61
Tokyo 60
Florence 58
San Diego 58
Falls Church 57
Verona 57
Helsinki 55
Brussels 54
Bologna 53
Singapore 52
Mountain View 50
San Mateo 49
Los Angeles 48
Paris 46
Abuja 42
Jinan 42
Madrid 41
Kunming 39
London 39
São Paulo 38
Padova 35
Silver Spring 34
Leiden 31
Munich 31
Napoli 31
Barcelona 30
Genova 30
Phoenix 30
Saluzzo 30
Athens 28
Sydney 28
Central District 27
Ottawa 27
Palermo 27
Redmond 27
Santiago 27
Istanbul 26
Rochester 26
Taipei 26
Zurich 25
Nürnberg 24
Amsterdam 23
Berlin 23
Buenos Aires 23
Council Bluffs 23
Lappeenranta 23
Zhengzhou 23
Copenhagen 22
Philadelphia 22
Wuhan 22
Des Moines 21
Duncan 21
Nanchang 21
Pavia 21
Mumbai 20
Bogotá 19
Hong Kong 19
Lachine 19
Moscow 19
Totale 20.978
Salva come PNG Salva come JPEG
Nome #
Prediction of survival in patients with thin melanoma: results from a multi-institution study. 770
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 682
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 558
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: A European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases 557
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis 484
Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases 453
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 429
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 349
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab 322
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 291
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 289
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 287
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 281
Metastasi cutanee da melanoma: l’esperienza della I Clinica Dermatologica di Torino 278
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 265
Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. 262
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 257
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. 239
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 233
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy 233
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 232
Giornale italiano di Dermatologia e Venereologia 224
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 219
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 213
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 209
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 208
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 203
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 203
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 199
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis 197
Dermoscopy and digital dermoscopy analysis of palmo-plantar equivocal pigmented skin lesions in Caucasians. 190
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 189
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 188
MiR-146a exerts differential effects on melanoma growth and metastatization 184
High nevus counts confer a favorable prognosis in melanoma patients 178
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. 178
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 175
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 172
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 170
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 168
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma 166
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force 165
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 164
Dermatite Flagellata e Melanonichia striata longitudinale da citostatici 163
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 163
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement 163
Adult-onset cutaneous mastocytosis in monozygotic twins. 161
Current status and perspectives in immunotherapy for metastatic melanoma 155
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 147
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives 142
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality 140
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 136
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma. 135
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 131
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 128
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 127
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 127
Precursori del melanoma? 122
Prognostic differences across sexes in melanoma patients: What has changed from the past? 120
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 120
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 116
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 116
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis. 115
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 114
Gruppo Italiano Polidisciplinare sul Melanoma: proposte per nuove studi 113
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 109
Dermatite flagellata e iperpigmentazione longitudinale a banda ungueale indotta da trattamento chemioterapico: descrizione di un caso. 108
T-Helper (Th)22, a Newly Identified Lymphocyte Subset, Increases 1-3 Months before an MS Relapse and It Is Not Sensitive to IFN beta 108
Fotoferesi: applicazioni terapeutiche “off-label” 107
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 105
Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: A multivariate analysis of 214 cases 104
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 104
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 104
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. 103
Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. 103
Dermatite flagellata e melanonichia striata longitudinale da citostatici. 102
Alopecia areata after COVID-19 vaccination 102
Linfociti circolanti T regolatori in pazienti psoriasici trattati con ciclosporina e farmaci biologici 101
Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma 101
Melanoma immunotherapy. 101
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei 100
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 99
The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments 99
Il melanoma primitivo sconosciuto 98
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 97
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 95
The risk of melanoma in airline pilots and cabin crew: A meta-analysis 94
The Risk of Melanoma in Pilots and Cabin Crew: UV Measurements in Flying Airplanes. 93
Gruppo Italiano Polidisciplinare sul melanoma; studi in corso e nuove proposte 93
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 91
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors. 91
Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation 91
Unknown Primary Melanoma: Worldwide Survey on Clinical Management. 91
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 90
'Aleukemic' granulomatous leukemia cutis. 89
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers. 89
Malattia di Destombes-Rosai-Dorfman ad esclusivo interessamento cutaneo: studio istologico, immunoistochimico ed ultrastrutturale di un caso. 88
Linfoma cutaneo CD56 positivo: presentazione di un caso 88
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 87
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 87
Totale 18.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.862
article - articoli 0
book - libri 0
conference - conferenze 26.191
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.153 0 0 0 0 0 0 0 0 0 0 747 406
2019/20205.361 281 200 299 692 426 732 570 421 493 463 387 397
2020/20213.732 475 235 272 222 320 325 253 180 332 346 282 490
2021/20225.649 319 190 256 313 623 212 281 293 235 334 983 1.610
2022/20238.708 1.098 653 206 675 815 2.045 771 644 878 196 451 276
2023/20243.467 473 644 307 282 287 633 179 226 56 342 38 0
Totale 38.973